Efficacy of Intermittent Fasting Versus Continuous Caloric Restriction in the Treatment of Significant Weight Regain After Bariatric Surgery

Launched by HOSPITAL UNIVERSITARIO SAN IGNACIO · Jan 4, 2025

Keywords

ClinConnect Summary

Patients meeting the inclusion criteria will be identified. Once identified, they will be asked to participate in the study and, if they accept, they will be asked to complete and sign the informed consent form. The study will consist of three phases: a selection phase, an adaptation phase (1 to 2 weeks), a weight loss phase (12 weeks) and a maintenance phase (12 weeks).

Selection Period (Visit 0)

The bariatric surgery, nutrition, and endocrinology consultation of the bariatric clinic will identify possible candidates. In addition, the use of dietary supplements will be reviewed according...

Gender

ALL

Eligibility criteria

• • Patients between 18 and 69 years of age treated with primary and/or secondary bariatric surgery with more than 1 year of postoperative.
• • 2.3.3 INCLUSION CRITERIA
• • 10% weight gain with respect to the minimum postoperative weight and/or
• • Weight gain rate ≥0.50% with respect to previous weight.
• • Supplementation with ferrous sulfate, cyanocobalamin and cholecalciferol, according to clinical criteria.
• • Not having modified the therapy in the last 3 months
• • Access to mobile phone with data.
• • Agree to participate in the study including signing informed consent.
• • 2.3.4 EXCLUSION CRITERIA.
• • Patient diagnosed with type 1 diabetes mellitus.
• • Patient diagnosed with type 2 diabetes mellitus treated with insulin.
• • History of an eating disorder such as anorexia or bulimia. • Untreated vitamin B12, iron, calcium, and/or vitamin D deficiency.
• • History of hospitalization for cardiovascular disease (angina, myocardial infarction, or stroke) 3 months prior to the study.
• • Use of antidepressant or anti-anxiety medications
• • Use of medications that affect the results of the study (weight loss medications)
• • Unable to keep a food diary or activity log for 7 consecutive days during screening
• • Cognitive impairment that, in the opinion of the principal investigator or study physician, would result in failure to cooperate with study procedures.
• • Active neoplastic disease.
• • Pregnancy or breast-feeding, or planning to become pregnant during the study period
• • Significant psychiatric illness, kidney disease, severe liver disease, or other illness that affects the ability to complete the study.